Indivior (INDV)
(Delayed Data from NSDQ)
$17.87 USD
+0.09 (0.51%)
Updated May 9, 2024 04:00 PM ET
After-Market: $17.88 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 40% (100 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | 0.46 | 0.39 | 57.00 |
Year Ago Quarter Estimate | 0.39 | -0.79 | 52.54 |
Next Quarter Estimate | 0.53 | -2.04 | 61.00 |
Next Year Estimate | 2.59 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 27.39 | 12.00 | 15.67 |
Next Year | 29.50 | 14.90 | 9.31 |
Last 5 Years | -0.20 | 5.50 | 8.10 |
Next 5 Years | NA | 22.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 11.62 | -5.88 |
Price/Book (MRQ) | 245.15 | 1.91 |
Price/Cash Flow (MRFY) | 9.77 | 9.59 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 0.44% | 0.82% |
Return on Equity (TTM) | 842.72% | -24.69% |
Debt to Equity (MRQ) | 23.50 | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.